Advertisement

Implantable Atrial Defibrillator: What Are the Future Perspectives?

  • W. Jung
  • C. Wolpert
  • S. Herwig
  • B. Lüderitz
Conference paper

Abstract

Atrial fibrillation (AF) is a frequent and costly health care problem, being the most common arrhythmia that leads to hospital admission. The overall prevalence of AF in the United States ranges from less than 1% in young, otherwise healthy individuals up to nearly 9% in elderly patients. AF may cause disabling symptoms and serious adverse effects such as impairment of cardiac function or thromboembolic events. Due to the limited efficacy of antiarrhythmic drugs for AF, several nonpharmacologic options have evolved, including pacemaker therapy, transvenous catheter ablation techniques, surgical procedures, and treatment with an implantable atrial defibrillator (IAD). The high prevalence of AF and its clinical complications, the poor efficacy of medical therapy in preventing recurrences, and dissatisfaction with alternative modes of therapy stimulated interest in an IAD [1]. We report on the worldwide experience with the first IAD, the Metrix system, model 3000 and 3020 (InControl Inc., Redmond, Wash., USA).

Keywords

Atrial Fibrillation Coronary Sinus Recurrent Atrial Fibrillation Atrial Fibrillation Episode Pectoral Region 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lüderitz B, Pfeiffer D, Tebbenjohanns J, Jung W (1966) Nonpharmacologic strategies for treating atrial fibrillation. Am J Cardiol 77:45A-52ACrossRefGoogle Scholar
  2. 2.
    Jung W, Lüderitz B (1997) Implantable atrial defibrillator: which results and indications. In: Raviele A (ed) Cardiac arrhythmias. Springer, Berlin Heidelberg New York, pp 100–109Google Scholar
  3. 3.
    Jung W, Wolpert C, Esmailzadeh B et al (1998) Specific considerations with the automatic implantable atrial defibrillator. J Cardiovasc Electrophysiol 9:S193–S201PubMedCrossRefGoogle Scholar
  4. 4.
    Jung W, Lüderitz B (1997) Implantable atrial defibrillator: quo vadis? (editorial) Pacing Clin Electrophysiol 20:2141–2145PubMedCrossRefGoogle Scholar
  5. 5.
    Jung W, Tebbenjohanns J, Wolpert C et al (1995) Safety, efficacy, and pain perception of internal atrial defibrillation in humans. Circulation 92:472 (abstr)CrossRefGoogle Scholar
  6. 6.
    Jung W, Lüderitz B (1998) Quality of life of patients with atrial fibrillation. J Cardiovasc Electrophysiol 9:S177–S186PubMedCrossRefGoogle Scholar
  7. 7.
    Lau CP, Tse HF, Lok NS et al (1977) Initial clinical experience with an implantable human atrial defibrillator. Pacing Clin Electrophysiol 20:220–225CrossRefGoogle Scholar
  8. 8.
    Jung W, Kirchhoff PG, Lau CP, Tse HF, Lüderitz B, for the Metrix System Clinical Investigational Group (1997) Therapy delivery with the METRIX automatic atrial defibrillation system: threshold stability and shock safety. J Am Coll Cardiol 29:78A (abstr)Google Scholar
  9. 9.
    Wellens HJJ, Lau CP, Lüderitz B et al, for the Metrix Investigators (1998) The atrioverter, an implantable device for treatment of atrial fibrillation. Circulation 98:1651–1656PubMedCrossRefGoogle Scholar
  10. 10.
    Jung W, Wolpert C, Herwig S et al (1998) Initial experience with the implantable atrial defibrillator. G Ital Cardiol 28 (suppl 1):592–594Google Scholar
  11. 11.
    Jung W, Wolpert C, Spehl S et al, for the Worldwide Metrix Investigators (1998) Worldwide experience with the Metrix implantable atrial defibrillator. In: Adornato E (ed) Rhythm control from cardiac evaluation to treatment. Edizioni Luigi Pozzi, Rome, pp 139–143Google Scholar
  12. 12.
    Reuter D, Ayers GM (1998) Future directions of electrotherapy for atrial fibrillation. J Cardiovasc Electrophysiol 9:S202–S210PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2000

Authors and Affiliations

  • W. Jung
    • 1
  • C. Wolpert
    • 1
  • S. Herwig
    • 1
  • B. Lüderitz
    • 1
  1. 1.Department of Medicine-CardiologyUniversity of BonnGermany

Personalised recommendations